Indicating that cardiovascular disease is the leading cause of death, David C. Collymore, MD, MBA, feels that genetic testing bears the potential to generate a significant impact on outcomes, “especially in individuals that die from sudden heart attacks.”
Drawing a comparison between overweight individuals who seem to have a normally functioning cardiovascular system over their life time and seemingly “normal” individuals who unexpectedly die of the disease, Dr Collymore asked “Is there a genetic predisposition as to why one succumbs to cardiovascular disease while the other one does not?”
Another disease area, in his opinion, that could gain from genetic testing is diabetes. “I manage a network of practices in the Bronx. Diabetes is probably the most prevalent condition in our patient population.” There definitely is a significant genetic predisposition to diabetes, Dr Collymore said, and genetic testing could make a difference. “There are so many different diabetes medications on the market. If genomic testing could guide the provider to identify the medication that would be most effective, that would be a tremendous breakthrough in healthcare.” We are nearing a point where we can see the effect of research in that particular area, he explained.
Dr Collymore continued, “In our practices, we also service a large number of individuals that suffer from addiction. Several studies have shown that certain individuals have a genetic predisposition to be addicted to certain substances. One case that stands out was a lady who had a dental procedure, who was prescribed an opiate pain medication by her dentist. She began to take it and found herself addicted to prescription drugs within a year. I remember speaking with her and she said ‘I didn’t ask for this. I only went in to have a simple extraction and I don’t know what happened.’” Dr Collymore thinks that the woman’s genetic composition might have an important role to play. “If we could display a genetic predisposition to addiction through genetic testing and then tailor our pain prescribing habits for that individual, that could also have a tremendous effect,” he concluded.
Study Finds Obesity May Worsen Multiple Sclerosis: Genetic Analysis Points to Causal Link
November 21st 2024A new study aimed at exploring the relationship between obesity and multiple sclerosis severity using genetic data finds that higher BMI and other obesity measures were associated with increased disability progression in patients with MS.
Read More
Higher Life’s Essential 8 Scores Associated With Reduced COPD Risk
November 21st 2024Higher Life’s Essential 8 (LE8) scores, especially those reflecting lower nicotine exposure and better sleep health, are inversely associated with chronic obstructive pulmonary disease (COPD) risk, emphasizing the importance of cardiovascular health (CVH) in disease prevention.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Study Highlights Key RA-ILD Risk Factors, Urges Early Screening
November 20th 2024This recent study highlights key risk factors for rheumatoid arthritis–associated interstitial lung disease (RA-ILD), emphasizing the importance of early screening to improve diagnosis and patient outcomes.
Read More
New Study Finds Risk Groups, Outpatient Care Barriers in Chronic Liver Disease
November 20th 2024Patients with chronic liver disease who were unable to establish care were 85% more likely to require recurrent hospitalizations. This group included a disproportionate number of women and individuals with physical limitations affecting their health.
Read More